Many transcription factors involved in resistance to CDDP have been differentially expressed in this study, such as NRA42 (Nuclear Receptor subfamily 4 group A member 2; P<0.001), an orphan nuclear receptor that confers chemoresistance in GC and colorectal cancer [61,62]. This evidence concerns the gene ESRRB and colorectal cancer.